Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment

The treatment landscape of multiple myeloma (MM) has evolved considerably with the FDA-approval of at least 15 drugs over the past two decades. Together with the use of autologous stem cell transplantation, these novel therapies have resulted in significant survival benefit for patients with MM. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Matthew, Xiao, Alexander, Yi, Dongni, Zanwar, Saurabh, Bianchi, Giada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689284/
https://www.ncbi.nlm.nih.gov/pubmed/36421358
http://dx.doi.org/10.3390/curroncol29110705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689284/
https://www.ncbi.nlm.nih.gov/pubmed/36421358
http://dx.doi.org/10.3390/curroncol29110705

Ejemplares similares